Biocon Slides 5% Ahead of Key Biocon Biologics Investment, Fundraise Review on 6th December
Shares of Biocon Ltd plummeted 5% after touching a day’s high of Rs 411.75 on 4th December. This happened after the firm said on Wednesday...
Tag : Biocon Ltd
Biocon Shares Gain 1% on VAI Status from USFDA
Shares of Biocon Ltd were trading in the green and 1% higher on 27 November after the company announced that the US Food and Drug...
Biocon Biologics Extends Civica Partnership to Sell Insulin; Shares Down 1%
Shares of Biocon Ltd fell 1% after touching a day’s high of Rs 361.35 on 17th October, despite the company’s subsidiary announcing a multi-year agreement...
Biocon Biologics’ Bengaluru Unit Gets 5 US FDA Observations, Shares Up 1%
Shares of Biocon Ltd rose 1% to a day’s high of Rs 364.80 on 5th September, after the company announced that the US Food and...
Biocon Hits 52-Week High After USFDA Nod for Key Diabetes Drug, Shares Up 1%
Shares of Biocon Ltd rose 1% to touch a day’s high of Rs 405.90 on 16th July, after the United States Food & Drug Administration...
Biocon Gains 1% After India Nod for Diabetes Drug Liraglutide
Shares of Biocon Ltd rose 1% to touch a day’s high of Rs 340 on 3rd June. This increase came after the company announced it...
Biocon, Viatris Receive EC Nod For Biosimilar Bevacizumab
Biocon Biologics Ltd, a subsidiary of Bengaluru-headquartered Biocon Ltd, has announced that Abevmy 100 & 400 mg, a biosimilar of Bevacizumab co-developed with Viatris Inc.,...